Taysha Gene Therapies aims to raise $200M Taysha Gene Therapies priced its shares at $6.00 in an underwritten public offering. The offering includes common stock and pre-funded warrants, aiming for $200M in gross proceeds. Taysha Gene Therapies shares fell 9.2%
Taysha Gene Therapies aims to raise $200M
Taysha Gene Therapies priced its shares at $6.00 in an underwritten public offering.
The offering includes common stock and pre-funded warrants, aiming for $200M in gross proceeds.
Taysha Gene Therapies shares fell 9.2% after-hours on the news.
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.
